Navigation Links
CTI Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients with Myelofibrosis
Date:6/17/2013

SEATTLE, June 17, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced results from a pooled analysis of data from completed Phase 1 and 2 studies of pacritinib, an oral JAK2/FLT3 inhibitor, demonstrating the safety and tolerability profile of pacritinib in patients with myelofibrosis. An integrated safety analysis of four completed Phase 1 and 2 studies totaled 191 patients who were treated with pacritinib for myeloid, primarily myelofibrosis, or lymphoid malignancies to quantify clinical toxicities, with a focus on hematologic effects. Other JAK2 inhibitors have generally been associated with increases in anemia and thrombocytopenia but this was not observed with pacritinib. This integrated safety data analysis showed that, regardless of initial platelet counts, pacritinib causes minimal further marrow suppression. Even patients with initial platelet counts <50,000/µL, a high-risk population, tolerated therapy, maintained stable blood and platelet counts and did not require dose reductions for thrombocytopenia. Grade 1 or 2 gastrointestinal events, particularly diarrhea, were the most common adverse events and may be controlled by early administration of standard anti-diarrheal agents. The analysis was presented during a poster session at the 18th Congress of the European Hematology Association (EHA) held June 13-16, 2013 in Stockholm, Sweden. 

Pacritinib is currently being evaluated in a randomized Phase 3 clinical trial, known as PERSIST-1, in patients with myelofibrosis. Because of pacritinib's relative lack of bone marrow suppression, there are no study entry restrictions due to thrombocytopenia or anemia and patients with platelet and red blood cell transfusion dependence are allowed to enroll in the ongoing PERSIST-1 trial. More details on this study can be found at www.clinicaltrials.gov. Pa
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Zimmer Announces Quarterly Dividend for Second Quarter of 2013
2. Uroplasty Announces Delay in Filing Form 10-K
3. Cempra Announces Proposed Public Offering of Common Stock
4. Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders
5. NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinsons Disease and Movement Disorders
6. Royalty Pharma Announces Offer May Lapse (Be Withdrawn)
7. Anthera Pharmaceuticals Announces Personnel Changes
8. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
9. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
10. HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)
11. Misonix, Inc. Announces the Grant of Patent by the United States Patent and Trademark Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... DUBLIN , Aug. 19, 2014 ... the "Pharmaceutical Contract Manufacturing - Global Strategic Business ... This report analyzes the worldwide markets for Pharmaceutical Contract ... Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms ... (Syrups, Suspensions, Gels, Creams & Ointments). The ...
(Date:8/19/2014)... , Aug. 19, 2014 Research and Markets ... by Type of Material, by Technology, by Application & by ... their offering. The demand for membranes is ... driving the market to $29.31 billion Membrane technology ... applications, such as water filtration and kidney dialysis. In modern ...
(Date:8/19/2014)... According to Kalorama Information, electronic medical records ... Data in healthcare a reality, and this a factor ... American Recovery and Reinvestment Act, the U.S. government dedicated ... penalties will start applying soon for use of paper ... study of the EMR industry, EMR 2014: The ...
Breaking Medicine Technology:Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
(Date:8/19/2014)... Top10BestSEOHosting.com has recently announced that ... recommended suppliers for the webmasters who want to ... According to the senior spokesman for Top10BestSEOHosting.com, these ... hosting products on the market and specializes in ... of online deals when service plans are purchased ...
(Date:8/19/2014)... has recently compared many popular hosting suppliers and announced ... recommended companies for webmasters who want to buy high ... an affordable price. , Both GoDaddy and iPage ... the lowest upfront costs (including some Joomla hosting products ... of options. , GoDaddy is a famous supplier ...
(Date:8/19/2014)... News) -- Lupus and other rheumatic diseases can ... which can delay a correct diagnosis for months, ... diseases can also cause these types of symptoms, ... in Maywood, Ill. Rheumatic disorders include autoimmune ... tissues, such as lupus, systemic vasculitis and ankylosing ...
(Date:8/19/2014)... ME (PRWEB) August 19, 2014 Drews Dental ... J. Drews, D.D.S., to vice president of the Maine Dental ... MDA for three years, Dr. Drews has now been sworn ... forward to serving his term as vice president and being ... as well as the First District Caucus in 2015. He ...
(Date:8/19/2014)... August 19, 2014 Following the completion of ... Hyatt Tampa Bay is proud to debut the highly ... project included a full revamp of all public spaces to ... rooms and suites, an all-new dining experience at 1823 Kitchen ... lobby. , With the introduction of 1823 Kitchen and Bar, ...
Breaking Medicine News(10 mins):Health News:Fatcow Awarded As One of the Best Web Hosting Suppliers at Top10bestseohosting.com 2Health News:Top10BestSEOHosting.com: Cheap Joomla Hosting Reviews Unveiled 2Health News:Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report 2Health News:Dr. Drews Elected VP of Maine Dental Association 2Health News:Grand Hyatt Tampa Bay Hotel Unveils the Finishing Touches of Its $20 Million Makeover 2
... Hosts First Annual Exclusive Wine ... Gala, WASHINGTON, Dec. 14 Starlight Starbright,Children,s ... Annual Exclusive Wine Dinner and Eighth Annual Taste ... events were hosted at the,award-winning Michel Richard Citronelle ...
... Provides Reliable, Quick Patient-Information Retrieval From ... JOLIET, Ill., Dec. 14 AT&T Inc. ... Oncology-Hematology Associates, Ltd. (JOHA) has,awarded AT&T a ... in addition to other network solutions. Continuing ...
... 14 Barr Pharmaceuticals,Inc. (NYSE: BRL ) ... has filed suits against Watson Pharmaceuticals (NYSE:,WPI) and ... NVS ) for,infringement of the patent protecting Duramed,s ... litigation in the,U.S. District Court for the District ...
... Classification for Innovative New Treatments, AMSTERDAM, December ... product ATIR has received approval for regulatory,classification as ... Task,Force (ITF), a division of the European Medicines ... eligible for EMEA procedures. As a,next step Kiadis ...
... crowded roadways face more than 50% risk of breathing trouble, ... with asthma who are exposed to traffic pollution are at ... a study that looked at children in the Mexican border ... States. , "Major cities along the northern and southern ...
... LTC Financial Partners Offers Newsletter & Online Help for Living Longer, ... ... their,life spans, many eyeing 100-plus, the odds of needing long term care,increase. One ... says Cameron Truesdell, CEO of LTC Financial Partners,(LTCFP), "is the insurance plus health ...
Cached Medicine News:Health News:Premier Children's Charity Sets Fundraising Record With Back-to-Back Events 2Health News:Premier Children's Charity Sets Fundraising Record With Back-to-Back Events 3Health News:Premier Children's Charity Sets Fundraising Record With Back-to-Back Events 4Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 2Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 3Health News:Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement 2Health News:Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement 3Health News:Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement 4Health News:ATIR Classified as "Cell Based" Medicinal Product by the EMEA 2Health News: Traffic Pollution Hurts Asthmatic Kids' Lungs 2Health News:As More Americans Live to 100, Long Term Care Insurance Leader Gives Health Assist 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: